RU2682622C2 - Комбинированное использование клинических факторов риска и молекулярных маркеров тромбоза для поддержки принятия клинических решений - Google Patents

Комбинированное использование клинических факторов риска и молекулярных маркеров тромбоза для поддержки принятия клинических решений Download PDF

Info

Publication number
RU2682622C2
RU2682622C2 RU2015119520A RU2015119520A RU2682622C2 RU 2682622 C2 RU2682622 C2 RU 2682622C2 RU 2015119520 A RU2015119520 A RU 2015119520A RU 2015119520 A RU2015119520 A RU 2015119520A RU 2682622 C2 RU2682622 C2 RU 2682622C2
Authority
RU
Russia
Prior art keywords
thrombosis
risk
input features
clinical
patient
Prior art date
Application number
RU2015119520A
Other languages
English (en)
Russian (ru)
Other versions
RU2015119520A (ru
Inventor
Барт Якоб БАККЕР
ОЙЕН Хендрик Ян ВАН
ДЕН ХАМ Рене ВАН
Original Assignee
Конинклейке Филипс Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Конинклейке Филипс Н.В. filed Critical Конинклейке Филипс Н.В.
Publication of RU2015119520A publication Critical patent/RU2015119520A/ru
Application granted granted Critical
Publication of RU2682622C2 publication Critical patent/RU2682622C2/ru

Links

Images

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Data Mining & Analysis (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
RU2015119520A 2012-10-25 2013-10-17 Комбинированное использование клинических факторов риска и молекулярных маркеров тромбоза для поддержки принятия клинических решений RU2682622C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261718242P 2012-10-25 2012-10-25
US61/718,242 2012-10-25
PCT/IB2013/059424 WO2014064585A1 (en) 2012-10-25 2013-10-17 Combined use of clinical risk factors and molecular markers for thrombosis for clinical decision support

Publications (2)

Publication Number Publication Date
RU2015119520A RU2015119520A (ru) 2016-12-20
RU2682622C2 true RU2682622C2 (ru) 2019-03-19

Family

ID=49956255

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015119520A RU2682622C2 (ru) 2012-10-25 2013-10-17 Комбинированное использование клинических факторов риска и молекулярных маркеров тромбоза для поддержки принятия клинических решений

Country Status (7)

Country Link
US (1) US20150278470A1 (cg-RX-API-DMAC10.html)
EP (1) EP2912584B1 (cg-RX-API-DMAC10.html)
JP (1) JP6335910B2 (cg-RX-API-DMAC10.html)
CN (1) CN104756117B (cg-RX-API-DMAC10.html)
BR (1) BR112015009056A2 (cg-RX-API-DMAC10.html)
RU (1) RU2682622C2 (cg-RX-API-DMAC10.html)
WO (1) WO2014064585A1 (cg-RX-API-DMAC10.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11568982B1 (en) 2014-02-17 2023-01-31 Health at Scale Corporation System to improve the logistics of clinical care by selectively matching patients to providers
US11114204B1 (en) 2014-04-04 2021-09-07 Predictive Modeling, Inc. System to determine inpatient or outpatient care and inform decisions about patient care
US10748659B2 (en) * 2015-03-10 2020-08-18 Abbott Cardiovascular Systems Inc. Method and system for predicting risk of thrombosis
US20160283686A1 (en) * 2015-03-23 2016-09-29 International Business Machines Corporation Identifying And Ranking Individual-Level Risk Factors Using Personalized Predictive Models
EP3439547A4 (en) * 2016-04-07 2019-08-28 White Anvil Innovations, LLC METHOD FOR ANALYZING DIGITAL DATA
US11682495B2 (en) * 2016-10-13 2023-06-20 Carnegie Mellon University Structured medical data classification system for monitoring and remediating treatment risks
KR101865110B1 (ko) * 2016-11-21 2018-06-07 재단법인 아산사회복지재단 급성뇌경색 발생시점 추정시스템, 방법 및 프로그램
US20180181718A1 (en) * 2016-12-23 2018-06-28 King Abdulaziz University Interactive clinical decision support system
EP3422011A1 (en) * 2017-06-28 2019-01-02 Koninklijke Philips N.V. Parameter value estimation in coagulation system
CN112654864B (zh) * 2018-09-13 2025-01-10 株式会社岛津制作所 数据解析装置
CN109324188B (zh) * 2018-10-11 2022-04-08 珠海沃姆电子有限公司 一种精准化动态尿液测量方法和系统
US11922301B2 (en) * 2019-04-05 2024-03-05 Samsung Display Co., Ltd. System and method for data augmentation for trace dataset
US11710045B2 (en) 2019-10-01 2023-07-25 Samsung Display Co., Ltd. System and method for knowledge distillation
US11610679B1 (en) 2020-04-20 2023-03-21 Health at Scale Corporation Prediction and prevention of medical events using machine-learning algorithms
US12094582B1 (en) 2020-08-11 2024-09-17 Health at Scale Corporation Intelligent healthcare data fabric system
US12080428B1 (en) 2020-09-10 2024-09-03 Health at Scale Corporation Machine intelligence-based prioritization of non-emergent procedures and visits
JP7623120B2 (ja) 2020-10-01 2025-01-28 キヤノンメディカルシステムズ株式会社 診療支援システム
CN112767350B (zh) * 2021-01-19 2024-04-26 深圳麦科田生物医疗技术股份有限公司 血栓弹力图最大区间预测方法、装置、设备和存储介质
CN115188476B (zh) * 2022-07-20 2025-04-18 西安市红会医院（西安市骨科研究所） 基于遗传学特征预测骨折合并深静脉血栓风险的方法
JP7252688B1 (ja) * 2022-12-28 2023-04-05 株式会社AiCAN 児童相談業務を支援する情報処理方法、プログラム、情報処理システム

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030069528A1 (en) * 2001-09-21 2003-04-10 Herz Frederick Stephan Michael Prevention and treatment of deep venous thrombosis
US20090089079A1 (en) * 2004-11-09 2009-04-02 The Brigham And Women's Hospital, Inc. System and method for determining whether to issue an alert to consider prophylaxis for a risk condition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2378898A1 (en) * 1999-07-23 2001-02-01 The Scripps Research Institute Method for measuring coagulant factor activity in whole blood
AUPR005600A0 (en) * 2000-09-12 2000-10-05 University Of Sydney, The Diagnostic assay
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
US20080255767A1 (en) * 2004-05-26 2008-10-16 Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Method and Device For Detection of Splice Form and Alternative Splice Forms in Dna or Rna Sequences
US20090298103A1 (en) 2008-05-20 2009-12-03 The University Of Vermont And State Agriculture College Predicting hemostatic risk; dependence on plasma composition

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030069528A1 (en) * 2001-09-21 2003-04-10 Herz Frederick Stephan Michael Prevention and treatment of deep venous thrombosis
US20090089079A1 (en) * 2004-11-09 2009-04-02 The Brigham And Women's Hospital, Inc. System and method for determining whether to issue an alert to consider prophylaxis for a risk condition

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
JENKINS P.V. et al., Elevated factor VIII levels and risk of venous thrombosis, British Journal of Haematology, 25.04.2012, pp. 653-663. *
PENCO S. et al., Assessment of the Role of Genetic Polymorphism in Venous Thrombosis Through Artificial Neural Networks, Annals of Human Genetics, 2005, N 69, pp. 693-706. *
PENCO S. et al., Assessment of the Role of Genetic Polymorphism in Venous Thrombosis Through Artificial Neural Networks, Annals of Human Genetics, 2005, N 69, pp. 693-706. JENKINS P.V. et al., Elevated factor VIII levels and risk of venous thrombosis, British Journal of Haematology, 25.04.2012, pp. 653-663. МОЗГОВОЙ П.В. Тромбогеморрагические осложнения после реконструктивных операций на брюшном отделе аорты и магистральных артериях нижних конечностей (профилактика, диагностика, лечение), Автореферат диссертации на соискание ученой степени доктора медицинских наук, Волгоград, 2004, с. 19. *
И.М. СЕЧЕНОВА, Лабораторные Методы Исследования Системы Свертывания Крови, Методические рекомендации, Второе издание, Москва, 2011, cc. 1-15. *
МОЗГОВОЙ П.В. Тромбогеморрагические осложнения после реконструктивных операций на брюшном отделе аорты и магистральных артериях нижних конечностей (профилактика, диагностика, лечение), Авто диссертации на соискание ученой степени доктора медицинских наук, Волгоград, 2004, с. 19. *

Also Published As

Publication number Publication date
BR112015009056A2 (pt) 2017-07-04
WO2014064585A1 (en) 2014-05-01
EP2912584B1 (en) 2020-10-07
US20150278470A1 (en) 2015-10-01
RU2015119520A (ru) 2016-12-20
CN104756117B (zh) 2019-01-29
JP6335910B2 (ja) 2018-05-30
EP2912584A1 (en) 2015-09-02
JP2016502650A (ja) 2016-01-28
CN104756117A (zh) 2015-07-01

Similar Documents

Publication Publication Date Title
EP2912584B1 (en) Combined use of clinical risk factors and molecular markers for thrombosis for clinical decision support
Spencer et al. Health effects associated with exposure to intimate partner violence against women and childhood sexual abuse: a burden of proof study
Munafò et al. Triangulating evidence through the inclusion of genetically informed designs
Walker et al. Costs of health care use by women HMO members with a history of childhood abuse and neglect
Gilpin et al. A preliminary validation of a family history assessment form to select women at risk for breast or ovarian cancer for referral to a genetics center
McGwin Jr et al. Improving the ability to predict mortality among burn patients
Jacobi et al. Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose?
EP3701534B1 (en) Molecular evidence platform for auditable, continuous optimization of variant interpretation in genetic and genomic testing and analysis
Gates et al. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools
Scorza et al. Adverse childhood experiences and perceived stress in early adulthood in the context of disadvantage
Card et al. The health effects of cesarean delivery for low-risk first births
Metintas et al. Menopause Rating Scale as a screening tool in rural Turkey
Cullinan et al. Accessibility and screening uptake rates for gestational diabetes mellitus in Ireland
Damian et al. Association of detected depression and undetected depressive symptoms with long-term mortality in a cohort of institutionalised older people
Lyons et al. Development and validation of an algorithm for identifying patients with hemophilia A in an administrative claims database
Verma et al. Physician-level variation in clinical outcomes and resource use in inpatient general internal medicine: an observational study
Birhan et al. Joint clinical and socio-demographic determinants of CD4 cell count and body weight in HIV/TB co-infected adult patients on HAART
Schneider et al. Quality of care in for-profit and not-for-profit health plans enrolling Medicare beneficiaries
Joo et al. Trait insights gained by comparing genome-wide association study results using different chronic obstructive pulmonary disease definitions
Hellwege et al. Predictive models for abdominal aortic aneurysms using polygenic scores and PheWAS-derived risk factors
Huque et al. Assessment of dementia risk scores in predicting mild cognitive impairment: A comparison of CogDrisk, CAIDE, LIBRA, and ANU-ADRI
Laditka et al. Evaluating hospital care for individuals with Alzheimer's disease using inpatient quality indicators
Thorsted et al. The De Morton Mobility Index (DEMMI) in hospitalized geriatric patients is associated with risk of readmission, mortality, and discharge to a post-acute care facility: A nationwide register-based cohort study
Basem et al. Interaction between atrial fibrillation or flutter and the CHA2DS2-VASc score on the risk of ischemic stroke: a population-based cohort study
Kennedy et al. Identification of patients with evolving coronary syndromes by using statistical models with data from the time of presentation

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20201018